Profil
Peter A. LaCrosse is currently the President & Chief Operating Officer at Precidiag, Inc. He previously worked as the Vice President-US Operations at febit holding GmbH and as the Chief of Staff at Arch Therapeutics, Inc. LaCrosse completed his undergraduate degree at Embry-Riddle Aeronautical University.
Aktiva positioner av Peter A. LaCrosse
| Företag | Position | Start |
|---|---|---|
Precidiag, Inc.
Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | President | - |
Tidigare kända positioner av Peter A. LaCrosse
| Företag | Position | Slut |
|---|---|---|
| ARCH THERAPEUTICS, INC. | Personalchef | - |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services Designs and develops technologies for DNA analysis | Företagsledare/Principal | - |
Peter A. LaCrosses utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Embry-Riddle Aeronautical University
Embry-Riddle Aeronautical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services Designs and develops technologies for DNA analysis | Health Services |
Arch Therapeutics, Inc.
Arch Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel approach to stop bleeding, control leaking and manage wounds during surgery, trauma & interventional care | Health Technology |
Precidiag, Inc.
Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | Technology Services |
















